170 related articles for article (PubMed ID: 19901960)
21. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
[TBL] [Abstract][Full Text] [Related]
22. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
24. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
25. Multilocus loss of heterozygosity allelotypes identify a genetic pathway associated with progression from low to high stage disease in neuroblastoma.
Chughtai SA; Genus T; Ramani P; Dyer S; Powell JE; McMullan D; Davison V; McConville CM;
Eur J Cancer; 2006 Aug; 42(12):1826-34. PubMed ID: 16872824
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
Srivatsan ES; Murali V; Seeger RC
Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
[TBL] [Abstract][Full Text] [Related]
27. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.
Buckley PG; Alcock L; Bryan K; Bray I; Schulte JH; Schramm A; Eggert A; Mestdagh P; De Preter K; Vandesompele J; Speleman F; Stallings RL
Clin Cancer Res; 2010 Jun; 16(11):2971-8. PubMed ID: 20406844
[TBL] [Abstract][Full Text] [Related]
29. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis.
Luttikhuis ME; Powell JE; Rees SA; Genus T; Chughtai S; Ramani P; Mann JR; McConville CM
Br J Cancer; 2001 Aug; 85(4):531-7. PubMed ID: 11506492
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling of 1p35-36 genes in neuroblastoma.
Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
[TBL] [Abstract][Full Text] [Related]
32. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
33. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
34. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
[TBL] [Abstract][Full Text] [Related]
35. Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.
De Preter K; Vandesompele J; Menten B; Carr P; Fiegler H; Edsjö A; Carter NP; Yigit N; Waelput W; Van Roy N; Bader S; Påhlman S; Speleman F
BMC Genomics; 2005 Jul; 6():97. PubMed ID: 16000168
[TBL] [Abstract][Full Text] [Related]
36. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
37. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
Gehring M; Berthold F; Edler L; Schwab M; Amler LC
Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
[TBL] [Abstract][Full Text] [Related]
38. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.
Passariello A; De Brasi D; Defferrari R; Genesio R; Tufano M; Mazzocco K; Capasso M; Migliorati R; Martinsson T; Siani P; Nitsch L; Tonini GP
Eur J Med Genet; 2013 Nov; 56(11):626-34. PubMed ID: 24035971
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations involving chromosome 1p in children with neuroblastoma.
Avigad S; Tamir Y; Yaniv I; Goshen J; Kaplinsky C; Cohen IJ; Zaizov R
Isr J Med Sci; 1994 Aug; 30(8):639-41. PubMed ID: 7913920
[TBL] [Abstract][Full Text] [Related]
40. [New insights into the genetic basis of neuroblastoma].
Speleman F; De Preter K; Hoebeeck J; Van Roy N; Vandesompele J
Verh K Acad Geneeskd Belg; 2007; 69(4):167-96. PubMed ID: 17821957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
